PPD is targeting growing demand for contract data analysis with a new biostatistics infrastructure that, it says, offers improved security and reporting.
The EMEA is fast tracking the review of data on H1N1 pandemic vaccines to ensure it has checked submissions before the northern hemisphere flu season, which starts in September.
Australian drug development firm Cancer Therapeutics (CTx) has selected IDBS’ E-workbook and ActivityBase platforms to manage its global drug development programmes.
There is a growing realisation in pharma that, to remain
competitive, paper-based trials are not the way forward. Instead,
electronic data capture (EDC) and management technology solutions
are now readily available and becoming more...
The need for better exploitation of clinical data is linked
directly to the general challenges facing drug development today as
development costs for new products have rocketed from $100m (€79m)
to $800m.
IDBS and In Silico Discovery have announced the formation of a
partnership in which the deal aims to integrate drug discovery data
and providing flexible access irrespective of where it is stored.
Phoenix Data Systems has recently launched an interactive voice
response (IVR) system and a range of new services to accompany its
current electronic data capture (EDC) technology.
New web based software, which can extract potentially life-saving
knowledge from data in minutes, has bioinformatic research
applications that could prove essential to laboratory technicians
wanting to improve diagnosis and treatment...
Drug research and development is facing a major problem with the
sheer influx of data generated, which threatens to further slow
down productivity, if its management and interpretation is not
efficiently dealt with.
IBM in the UK and US based IDBS, a provider of data management,
analysis and decision-making software for drug discovery, this week
announced a global strategic alliance.